Packaging Component List For Approved Drugs Could Ease PAC Filings
Executive Summary
FDA and the pharmaceutical industry should draft a list of "CDER-approved" container closure components as a supplement to the upcoming packaging post-approval changes guidance, participants recommended at an FDA/American Association of Pharmaceutical Scientists workshop on packaging and analytical method post-approval changes.